MilWealth Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7
| Closed | -$317 | – | 61 |
|
|
2022
Q3 | $317 | Hold |
7
| – | – | ﹤0.01% | 59 |
|
|
2022
Q2 | $377 | Hold |
7
| – | – | ﹤0.01% | 69 |
|
|
2022
Q1 | $534 | Hold |
7
| – | – | ﹤0.01% | 76 |
|
|
2021
Q4 | $1.34K | Hold |
7
| – | – | ﹤0.01% | 144 |
|
|
2021
Q3 | $1.78K | Hold |
7
| – | – | ﹤0.01% | 145 |
|
|
2021
Q2 | $1.7K | Hold |
7
| – | – | ﹤0.01% | 56 |
|
|
2021
Q1 | $1.98K | Hold |
7
| – | – | ﹤0.01% | 58 |
|
|
2020
Q4 | $1.68K | Hold |
7
| – | – | ﹤0.01% | 52 |
|
|
2020
Q3 | $1.64K | Hold |
7
| – | – | ﹤0.01% | 53 |
|
|
2020
Q2 | $2.29K | Hold |
7
| – | – | ﹤0.01% | 57 |
|
|
2020
Q1 | $1.77K | Hold |
7
| – | – | ﹤0.01% | 62 |
|
|
2019
Q4 | $2.14K | Hold |
7
| – | – | ﹤0.01% | 65 |
|
|
2019
Q3 | $1.8K | Buy |
+7
| New | +$1.8K | ﹤0.01% | 65 |
|